N/A
N=145
Survivorship and Outcomes of Robot Assisted Medial Partial Knee Replacement
Unicompartmental Knee Arthroplasty
Bottom Line
View on ClinicalTrials.gov: NCT01845597 ↗Enrolled (actual)
145
Serious AEs
0.0%
Results posted
Jul 2023
Primary outcome: Primary: 10 Year Survivorship of Components — 110 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- MAKOplasty® medial UKA (Procedure)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- Northwest Surgical Specialists, Vancouver
- Primary completion
- Feb 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY 10 Year Survivorship of Components |
110 | — |
| SECONDARY 5 Year Survivorship of Components |
132 | — |
| SECONDARY 2 Year Survivorship of Components |
144 | — |
Summary
The purpose of this study is to determine the survivorship rate of robotic assisted medial partial knee replacement at a two, five, and ten years.
Eligibility Criteria
Inclusion Criteria
- over 21 years of age
- underwent primary robotically guided UKA and received a medial MCK onlay implant by the investigating surgeon
- at least 24 months post-operative
Exclusion Criteria
- Patients will be excluded from participation in the study if they are cognitively unable to answer study questions
Data sourced from ClinicalTrials.gov (NCT01845597). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.